SFE : Summary for Safeguard Scientifics, Inc. New - Yahoo Finance

U.S. Markets close in 6 hrs 8 mins

Safeguard Scientifics, Inc. (SFE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.750.00 (0.00%)
As of 9:30AM EST. Market open.
People also watch
BVSNRNWKCNETSCMRVRSN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close12.75
Open12.75
Bid0.00 x
Ask0.00 x
Day's Range12.75 - 12.75
52 Week Range10.60 - 14.75
Volume106
Avg. Volume53,319
Market Cap258.04M
Beta1.39
PE Ratio (TTM)-17.61
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire14 days ago

    Safeguard Scientifics To Present At The 2nd Annual Disruptive Growth & Healthcare Conference

    RADNOR, Pa., Feb. 13, 2017 /PRNewswire/ --  Safeguard Scientifics, Inc.  (NYSE: SFE) Senior Vice President and Chief Financial Officer, Jeffrey B. McGroarty , will present at the 2 nd Annual Disruptive ...

  • PR Newswire19 days ago

    Propeller Health Enters into Collaboration to Connect Breezhaler™ Devices to the Propeller Platform

    MADISON, Wis., Feb. 8, 2017 /PRNewswire/ -- Propeller Health, the leading digital health solution for respiratory medicine, and Novartis Pharma AG (NVS) today announced a collaboration to develop a custom add-on sensor for the Breezhaler™ inhaler, a device used for the company's portfolio of COPD treatments (Ultibro™ Breezhaler™, Onbrez™ Breezhaler™ and Seebri™ Breezhaler™), connecting these medications to Propeller's digital health platform. As patients use the Breezhaler™ inhaler, a patented capsule-based dry powder inhaler (DPI) for treatment of COPD, the new custom sensors will allow for passively recording and transmitting compliance data, better informing patients and their physicians of adherence and other treatment factors through the Propeller platform. Propeller has regulatory clearance to help patients and their physicians better understand asthma and COPD, and help to improve the symptoms and outcomes of these chronic respiratory diseases.

  • PR Newswire25 days ago

    Safeguard Scientifics to Release Fourth Quarter and Full-Year 2016 Financial Results on Thursday, March 2nd

    RADNOR, Pa., Feb. 2, 2017 /PRNewswire/ --  Safeguard Scientifics, Inc.  (NYSE:SFE) will release its  financial results  for the fourth quarter and full-year ended December 31, 2016 prior to market open ...